CN113056457B - 用于治疗cns疾病的前药 - Google Patents
用于治疗cns疾病的前药 Download PDFInfo
- Publication number
- CN113056457B CN113056457B CN201980075181.5A CN201980075181A CN113056457B CN 113056457 B CN113056457 B CN 113056457B CN 201980075181 A CN201980075181 A CN 201980075181A CN 113056457 B CN113056457 B CN 113056457B
- Authority
- CN
- China
- Prior art keywords
- methyl
- inden
- dihydro
- phenyl
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/037—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements with quaternary ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201800947 | 2018-12-03 | ||
| DKPA201800947 | 2018-12-03 | ||
| PCT/EP2019/082715 WO2020114853A1 (en) | 2018-12-03 | 2019-11-27 | Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113056457A CN113056457A (zh) | 2021-06-29 |
| CN113056457B true CN113056457B (zh) | 2025-06-20 |
Family
ID=69061245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980075181.5A Active CN113056457B (zh) | 2018-12-03 | 2019-11-27 | 用于治疗cns疾病的前药 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11535600B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3891134A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7583719B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113056457B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020114853A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113056457B (zh) | 2018-12-03 | 2025-06-20 | H.隆德贝克有限公司 | 用于治疗cns疾病的前药 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992010192A1 (en) * | 1990-12-04 | 1992-06-25 | H. Lundbeck A/S | Indan derivatives |
| WO2005016901A1 (en) * | 2003-08-18 | 2005-02-24 | H. Lundbeck A/S | Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8427125D0 (en) | 1984-10-26 | 1984-12-05 | Lundbeck & Co As H | Organic compounds |
| HU198005B (en) | 1984-12-04 | 1989-07-28 | Sandoz Ag | Process for producing mevqlolakton, derivatives, its indene-analogues and pharmaceutical compositions containing them |
| DK55192D0 (da) | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
| US6221335B1 (en) | 1994-03-25 | 2001-04-24 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| KR100477070B1 (ko) | 1994-03-25 | 2006-04-21 | 이소테크니카 인코포레이티드 | 중수소화작용에의한의약품의효능강화법 |
| JP2001517666A (ja) | 1997-09-23 | 2001-10-09 | 藤沢薬品工業株式会社 | チアゾール誘導体 |
| US6350786B1 (en) | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| SE9904850D0 (sv) | 1999-12-30 | 1999-12-30 | Pharmacia & Upjohn Ab | Novel process and intermediates |
| CA2569843A1 (en) | 2004-06-08 | 2005-12-22 | A. Carlsson Research Ab | New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
| RU2366654C2 (ru) | 2004-06-08 | 2009-09-10 | ЭнЭсЭйБи, ФИЛИАЛ АФ НЕУРОСЕРЧ СВИДЕН АБ, СВЕРИЙЕ | Новые дизамещенные фенилпиперидины/пиперазины в качестве модуляторов допаминовой нейротрансмиссии |
| TWI453198B (zh) | 2005-02-16 | 2014-09-21 | Lundbeck & Co As H | 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s)-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法 |
| JP2008530039A (ja) | 2005-02-16 | 2008-08-07 | ハー・ルンドベック・アクチエゼルスカベット | トランス−1−((1r,3s)−6−クロロ−3−フェニルインダン−1−イル)−3,3−ジメチルピペラジンの酒石酸塩およびリンゴ酸塩 |
| TWI376373B (en) | 2005-02-16 | 2012-11-11 | Lundbeck & Co As H | Crystalline base of a pharmaceutical compound |
| US7863274B2 (en) | 2005-07-29 | 2011-01-04 | Concert Pharmaceuticals Inc. | Deuterium enriched analogues of tadalafil as PDE5 inhibitors |
| CN101273024A (zh) | 2005-07-29 | 2008-09-24 | 康瑟特制药公司 | 新颖苯并[d][1,3]-二氧杂环戊烯衍生物 |
| EP2998288B1 (en) | 2005-12-01 | 2022-08-24 | ACADIA Pharmaceuticals Inc. | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity |
| WO2008086158A1 (en) | 2007-01-04 | 2008-07-17 | Smithkline Beecham Corporation | Benzodihydroquinazoline as pi3 kinase inhibitors |
| US8198305B2 (en) | 2007-04-13 | 2012-06-12 | Concert Pharmaceuticals Inc. | 1,2-benzisoxazol-3-yl compounds |
| US7528131B2 (en) | 2007-04-19 | 2009-05-05 | Concert Pharmaceuticals Inc. | Substituted morpholinyl compounds |
| EP1997479A1 (en) | 2007-05-31 | 2008-12-03 | Helm AG | Stabilized amorphous candesartan cilexetil compositions for oral administration |
| US20090062303A1 (en) | 2007-08-29 | 2009-03-05 | Protia, Llc | Deuterium-enriched ziprasidone |
| MX2010012037A (es) | 2008-05-07 | 2010-11-30 | Lundbeck & Co As H | Composiciones y uso utiles para tratar trastornos cognitivos. |
| JP2012504560A (ja) | 2008-10-03 | 2012-02-23 | ハー・ルンドベック・アクチエゼルスカベット | 経口製剤 |
| EP2362865A2 (en) | 2008-10-28 | 2011-09-07 | Concert Pharmaceuticals Inc. | Deuterated 2-propylpentanoic acid compounds |
| JP2012506904A (ja) | 2008-10-28 | 2012-03-22 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | 難水溶性成分のためのメソ多孔性材料賦形剤 |
| TW201102370A (en) * | 2009-07-07 | 2011-01-16 | Lundbeck & Co As H | Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl piperazine |
| US8557994B2 (en) | 2009-07-27 | 2013-10-15 | Daljit Singh Dhanoa | Deuterium-enriched pyridinonecarboxamides and derivatives |
| US8658236B2 (en) | 2009-08-21 | 2014-02-25 | Deuteria Beverages, Llc | Alcoholic compositions having a lowered risk of acetaldehydemia |
| KR101149529B1 (ko) | 2009-09-11 | 2012-05-25 | 한국화학연구원 | 인덴온 유도체 및 이를 포함하는 약학적 조성물 |
| CN102020522A (zh) | 2009-09-21 | 2011-04-20 | 陈松源 | 氘代药物的制备方法和应用 |
| US8278460B2 (en) | 2009-10-15 | 2012-10-02 | Concert Pharmaceuticals, Inc. | Substituted benzimidazoles |
| WO2011059080A1 (ja) | 2009-11-16 | 2011-05-19 | 第一三共株式会社 | 同位体置換されたジアミン誘導体 |
| EP2521711B1 (en) | 2010-01-07 | 2017-08-16 | Alkermes Pharma Ireland Limited | Quaternary ammonium salt prodrugs |
| EP2639216B1 (en) | 2010-11-09 | 2018-07-11 | Kaneka Corporation | Halogenated indenones and method for producing optically active indanones or optically active indanols by using same |
| EP2661427A1 (en) | 2011-01-07 | 2013-11-13 | H. Lundbeck A/S | Method for resolution of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1r,3s)-6-chloro-3-phenyl-indan, 1-yl)-3,3-dimethyl-piperazine |
| US9359376B2 (en) | 2011-04-08 | 2016-06-07 | Sphaera Pharma Pte. Ltd | Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds |
| LT3135656T (lt) | 2011-06-20 | 2019-04-25 | H. Lundbeck A/S | Deuterinti 1-piperazin-3-fenilindanai, skirti šizofrenijos gydymui |
| EP2903979B1 (en) * | 2012-10-04 | 2020-08-19 | Inhibikase Therapeutics, Inc. | Novel compounds, their preparation and their uses |
| CA2893256A1 (en) * | 2012-12-11 | 2014-06-19 | Pfizer Inc. | Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1 |
| AR094054A1 (es) | 2012-12-19 | 2015-07-08 | H Lundbeck As | 6-cloro-3-(fenil-d₅)-inden-1-ona y uso de la misma |
| CN112930341A (zh) | 2018-10-29 | 2021-06-08 | H.隆德贝克有限公司 | 无定形的具有式(i)的化合物和无定形的具有式(i)的化合物的盐 |
| CN113056457B (zh) | 2018-12-03 | 2025-06-20 | H.隆德贝克有限公司 | 用于治疗cns疾病的前药 |
-
2019
- 2019-11-27 CN CN201980075181.5A patent/CN113056457B/zh active Active
- 2019-11-27 WO PCT/EP2019/082715 patent/WO2020114853A1/en not_active Ceased
- 2019-11-27 EP EP19828958.9A patent/EP3891134A1/en active Pending
- 2019-11-27 JP JP2021529329A patent/JP7583719B2/ja active Active
- 2019-11-27 US US17/297,717 patent/US11535600B2/en active Active
-
2022
- 2022-11-23 US US18/058,587 patent/US12071416B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992010192A1 (en) * | 1990-12-04 | 1992-06-25 | H. Lundbeck A/S | Indan derivatives |
| WO2005016901A1 (en) * | 2003-08-18 | 2005-02-24 | H. Lundbeck A/S | Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020114853A1 (en) | 2020-06-11 |
| JP7583719B2 (ja) | 2024-11-14 |
| US12071416B2 (en) | 2024-08-27 |
| JP2022509965A (ja) | 2022-01-25 |
| CN113056457A (zh) | 2021-06-29 |
| US20230159478A1 (en) | 2023-05-25 |
| EP3891134A1 (en) | 2021-10-13 |
| US20220033367A1 (en) | 2022-02-03 |
| US11535600B2 (en) | 2022-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2024023266A1 (en) | Novel compounds | |
| JP7019000B2 (ja) | 2環性複素環化合物 | |
| IL152531A (en) | History of 8 - (3 - carboxyamido - 3 - phenylpropyl) - 3 - (isopropyl - 5 - methyl - H4 - 4, 2, 1 – triazole - 4 - il) - tropane, drugs containing them, their preparation and some new intermediate compounds | |
| US12624010B2 (en) | Dihydrooxazole and thiourea derivatives modulating the NLRP3 inflammasome pathway | |
| CA3184924A1 (en) | Immunomodulator | |
| WO2020254697A1 (en) | Fused 1,2 thiazoles and 1,2 thiazines which act as nl3p3 modulators | |
| CN113845558A (zh) | 高效糖皮质激素 | |
| KR20100085142A (ko) | C-met/hgfr 억제제의 다형체 | |
| JP2024500101A (ja) | 化合物の固体形態 | |
| US12071416B2 (en) | Prodrugs of 4-( (1R, 3S)-6-chloro-3-phenyl-2, 3-dihydro-1H-inden-1-yl)-1,2, 2-trimethylpiperazine and 4-( (1R, 3S)-6-chloro-3-(phenyl-D5)-2, 3-dihydro-1H-inden-1-yl)-2, 2-dimethyl-1 (methyl-D3) piperazine | |
| TW202519227A (zh) | 稠環衍生物、其製備方法及其在醫藥上的應用 | |
| HK40053331A (en) | Prodrugs for the treatment of cns disease | |
| JP5181674B2 (ja) | 光学活性なジヒドロピリジン誘導体の酸付加塩 | |
| WO2023118521A1 (en) | Dihydro-oxazol derivative compounds | |
| HK40053331B (en) | Prodrugs for the treatment of cns disease | |
| JP2024521129A (ja) | ピラゾロヘテロアリール誘導体の薬学的に許容される塩及びその結晶形 | |
| JP2008290988A (ja) | 光学活性なジヒドロピリジン誘導体の酸付加塩を含有する医薬 | |
| EA048581B1 (ru) | Производные дигидрооксазола и тиомочевины или мочевины, модулирующие путь nlrp3-инфламмасомы | |
| WO2025133307A1 (en) | Heterocyclic modulators of the nlrp3 inflammasome pathway | |
| KR20080087803A (ko) | 디히드로피리딘 유도체의 산부가염 | |
| HK40070300A (en) | Highly potent glucocorticoids | |
| CN118414335A (zh) | 作为Src抑制剂的化合物 | |
| EP0573548A1 (en) | Neuro-protective agents. | |
| HK1078573B (en) | Tropane derivatives useful in therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40053331 Country of ref document: HK |
|
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20210629 Assignee: NHWA PHARMA. Corp. Assignor: H.Lundbeck gmbh Contract record no.: X2022990000498 Denomination of invention: 4-((1R,3S)-6-Chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl)-1,2,2-trimethylpiperazine and 4-(( 1R,3S)-6-Chloro-3-(phenyl-d5)-2,3-dihydro-1H-inden-1-yl)-2,2-dimethyl- Prodrugs of 1-(methyl-d3)piperazine License type: Exclusive License Record date: 20220811 |
|
| EE01 | Entry into force of recordation of patent licensing contract | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |